ARTICLE | Company News
BioReliance, GenVec Inc deal
July 15, 2002 7:00 AM UTC
BREL will provide for GNVC 100 liter scale manufacturing services and related testing for GNVC's BioBypass angiogen and TNFerade adenoviral vector. BioBypass is in Phase II testing for coronary arter...